SECOND WHO CONSULTATION ON A GLOBAL ACTION PLAN FOR ...
Transcript of SECOND WHO CONSULTATION ON A GLOBAL ACTION PLAN FOR ...
15 July 2011
1
SECOND WHO CONSULTATION ON
A GLOBAL ACTION PLAN FOR INFLUENZA VACCINES
12 - 14 July 2011, Geneva, Switzerland, WHO Headquarters
FINAL LIST OF PARTICIPANTS
Professor Jon Abramson Professor and Chair
Pediatrics
Wake Forest University Baptist Medical Center
27157 Winston-Salem
United States of America
Dr Carmen Amela Director General for Public Health and Foreign Health
Ministry of Health, Social Policy and Equality
28071 Madrid
Spain
Professor Ashraf Bayoumi Head
Central Administration of Pharmaceutical Affairs
Egyptian Drug Authority
Cairo, Egypt
Dr Martin Bachmann Chief Scientific Officer
Cytos Biotechnology AG
Wagistrasse 25
8592 Schlieren
Switzerland
Dr David Behnam Pandemic Preparedness Initiative, Division for Health, Education, Social Protection
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH
65726 Eschborn
Germany
15 July 2011
2
Mr Simeon Bennett Health and Science Reporter
Bloomberg News
1204 Geneva
Switzerland
Dr Cornelia Betsch Scientific Manager
Center of Empirical Research in Economics and Behavioral Sciences
University of Erfurt
Nordhäuser Str. 63
99089 Erfurt
Germany
Dr John Boslego Director
Vaccine Development Global Program
PATH
20001 Washington
United States of America
Dr Rick A. Bright Acting Chief, Antivirals Advanced Development
International Program Lead
Influenza Division, Office of the Director
Biomedical Advanced Research and Development Authority (BARDA)
US Department of Health and Human Services (HHS)
DHHS/OS/ASPR/BARDA
330 Independence Ave, SW RM G640
Washington, DC 20201
Professor Harry Campbell Centre for Population Health Sciences
University of Edinburgh
EH89AG Edinburgh
United Kingdom of Great Britain and Northern Ireland
Professor Daniel Camus Chargé de mission Grippe, Délégation interministérielle à la Lutte contre la Grippe aviaire
(Service du Premier Ministre)
DILGA
Ministère de la Santé et des Sports
75350 Paris
France
15 July 2011
3
Dr Ze Chen Assistant General Director, Influenza Expert
Shanghai Institute of Biological Products
200052 Shanghai
The People's Republic of China
Ms Malinee Chittaganpitch Medical Scientist
National Institute of Health
11000 Nonthaburi
Thailand
Professor Klaus Cichutek President
Paul-Ehrlich-Institut
63225 Langen
Germany
Dr Kathleen L. Coelingh Senior Director
Medical & Scientific Affairs
MedImmune Advancing Science for Better Health
MedImmune Inc.
94111 San Francisco
United States of America
Dr Nicolas Collin Head
Vaccine Formulation Laboratory
University of Lausanne
1066 Epalinges sur Lausanne
Switzerland
Dr Manon Cox President and CEO
Protein Sciences Corporation
06450 Meriden
United States of America
Dr Nancy J. Cox Director of Influenza Division, National Center for Immunization and Respiratory Diseases
National Center for Infectious Diseases, Centers for Disease Control and Prevention
GA 30333 Atlanta
United States of America
15 July 2011
4
Dr William Cracknell Senior Technical Advisor
Global Influenza
CSL Biotherapies
3052 Parkville
Australia
Professor Abdolhossein Dalimi Director General
Razi Vaccine & Serum Research Institute
Karaj
Islamic Republic of Iran
Dr Giuseppe Del Giudice Head Translation Medicine
Novartis Vaccines
Novartis Vaccines and Diagnostics S.p.A, Divisione Biologici et Farmaceutici
Siena
Italy
Dr Rajeev M. Dhere Sr. Director, Vaccine Production
Vaccine Department
Serum Institute of India Ltd.
411 028 Pune
India
Mr Toon Digneffe Director
Government Affairs & Public Policy
Baxter
1420 Braine L'Alleud
Belgium
Dr Daria Donati Core team leader
GE Healthcare
75184 Uppsala
Sweden
Ms Thea Emmerling First Counsellor
Permanent Delegation of the EU to the International Organizations in Geneva
Rue du Grand Pré 66
1211 Geneva
Switzerland
15 July 2011
5
Dr Othmar Engelhardt Principal Scientist
Division of Virology
National Institute for Biological Standards and Control
EN6 3QG Hertfordshire
United Kingdom of Great Britain and Northern Ireland
Dr Harvey Fineberg President
Institute of Medicine
20001 Washington
United States of America
Dr Donald P. Francis Executive Director
Global Solutions for Infectious Diseases
94080 South San Francisco
United States of America
Dr Carlos Franco-Paredes Infectious Disease Consultant
Phoebe Putney Memorial Hospital
31721 Albany
United States of America
Dr Mohammed Gheisarzadeh Technical Officer
Food and Drug Control
Ministry of Health and Medical Education (MOHME)
Fakher Razi Street
Tehran
Islamic Republic of Iran
Dr Bruce Gellin Deputy Asst. Secretary for Health
National Vaccine Program Office
Department of Health and Human Services
20201 Washington
United States of America
Mr Eduard Geuns Director
Regulatory Affairs
Abbott Biologicals B.V.
NL-1380 DA WEESP
The Netherlands
15 July 2011
6
Dr Jill Glasspool-Malone Consultant
RW Malone MD, LLC.
30143 Jasper
United States of America
Dr Gary Grohmann Director, Immunobiology & Manager of Prescription Medicines
Office of Laboratories and Scientific Services
Therapeutic Goods Administration
2606 Woden
Australia
Dr Ian Gust Professorial Fellow
Department of Microbiology and Immunology
The University of Melbourne
3010 Melbourne
Australia
Dr Doan Ngoc Hai Secretary for Vice Minister of Health Dr. Nguyen Thi Kim Tien
Ministry Office
Ministry of Health
Hanoi
Viet Nam
Professor Frederick Hayden Influenza Research Coordinator
International activities-Science Funding
The Wellcome Trust
NW1 2BE London
United Kingdom of Great Britain and Northern Ireland
Dr Norbert Hehme Vice President
Global External Relations
GSK Biologicals
01069 Dresden
Germany
Dr Jan T. Hendriks Account Manager
International Support
National Institute for Public Health and Environment (RIVM)
NL-3720 AL Bilthoven
The Netherlands
15 July 2011
7
Dr Nurma Hidayati Head
Sub Directorate of New Product Evaluation
National Agency of Drug and Food Control
10560 Jakarta Pusat
Indonesia
Dr Le Kim Hoa Vice Director, QC & QA, R&D/Head of QA
Institute of Vaccine and Medical Biologicals
Khanh Hoa Province
Viet Nam
Mrs Althea House Chief, Non-Pharmaceutical Intervention
Pandemic Preparedness
Public Health Agency of Canada
K1A 0K9 Ottawa
Canada
Ms Patcha Incomserb Medical Scientist
Department of Medical Sciences
MOPH
Thailand
11000 Nonthaburi
Thailand
Dr Makiyo Iwata International Affairs Division
Ministry of Health, Labour and Welfare
Tokyo
Japan
Dr Suresh Jadhav Executive Director
Quality Assurance & Regulatory Affairs
Serum Institute of India Ltd.
411028 Pune
India
Dr Istvan Jankovics National Center For Epidemiology
1097 Budapest
Hungary
15 July 2011
8
Mr Andrew Jenner Director
IFPMA (International Federation of Pharmaceutical Manufacturers & Associations)
15, chemin Louis-Dunant
P.O. Box 195
1211 Geneva
Switzerland
Dr Seog-Youn Kang Director, Biologics Division
Biopharmaceuticals & Herbal Medicine Evaluation Department
Korean Food and Drug Administration
Seoul
Republic of Korea
Dr Ruth Karron Professor
Center for Immunization Research, Dept of International Health
Johns Hopkins Bloomberg School of Public Health
21205 Baltimore
United States of America
Mr Ken Kelley CEO
PaxVax
94025 Menlo Park
United States of America
Mr Sjirk Kok General Manager
Abbott
1381 CP Weesp
The Netherlands
Dr Xavier Kurz Pharmacovigilance, Safety and Efficacy of
Medicines
European Medicines Agency
7 Westferry Circus
Canary Wharf
London, E14 4HB
UK
15 July 2011
9
Dr Rosanna Lagos Coordinadora
Centro para vacunas en Desarollo-Chile
Hospital de Niños Roberto del Rio
Santiago
Chile
Mr Axel Lambert de Rouvroit Managing Partner, Public Safety
Health Security Associates
77930 Fleury-en-Biere
France
Mr Peter Latham President
Latham BioPharm Group
01754 Maynard
United States of America
Dr Patrick Le Courtois Head, Human Medicines Development and
Evaluation
European Medicines Agency
7 Westferry Circus,
Canary Wharf,
London, E14 4HB
UK
Dr Vernon Lee Adjunct Associate Professor
Department of Epidemiology and Public Health
Yong Loo Lin School of Medicine
National University of Singapore
Singapore
Mr Olivier Loeillot Head of Enterprise Solutions
Life Sciences, GE Healthcare
68300 Saint Louis
France
Professor Johannes Lower Former Director
Paul-Ehrlich-Institut
D-63225 Langen
Germany
15 July 2011
10
Dr Robert Malone Consultant
RW Malone MD, LLC.
30143 Jasper
United States of America
Dr Maria Julia Marinissen Director
Office of Policy and Planning, Division of International Health Security
U.S. Department of Health and Human Services
20201 Washington
United States of America
Dr José Ricardo Pio Marins Ministry of Health
SCS Quadra 4 bloco A unidade 4 , 4 andar, Coordenação Geral de Doenças Transmissíveis,
Edifício Principal. Code 70.304-000
74304000 Brasília-DF, Federal District
Brazil
Mr John Mashulski Sales Leader Enterprise Solutions
Life Sciences, GE Healthcare
099253 Singapore
Singapore
Dr James Matthews Vice President
Health & Science Policy
Sanofi Pasteur Inc.
20004 Washington DC
United States of America
Dr Maggie Habib Meawad OES - Office of International Health and Biodefense
U.S. Department of State
2201 C Street, NW | Washington, DC 20520
Dr Karen Midthun Director
Center for Biologics Evaluation and Research (CBER)
Food and Drug Administration (FDA)
20852 Bethesda MD
United States of America
15 July 2011
11
Dr Daniel Miller Director, Intl Influenza Unit
US Dept of Health and Human Services
20201 Washington
United States of America
Professor Elizabeth Miller Advisor
Consultant Epidemiologist
Immunization, Hepatitis and Blood Safety
Health Protection Agency, Centre for Infections
NW9 5EQ London
United Kingdom of Great Britain and Northern Ireland
Dr Rajiv Modi Managing Director
Cadila Pharmaceuticals Ltd
382210 Ahmedabad
India
Dr Arnold Monto The Thomas Francis Jr. Professor
Epidemiology
The University of Michigan School of Public Health
MI 48109-2029 Ann Arbor
United States of America
Dr Harish Nair Research Fellow
Centre for Population Health Sciences
The University of Edinburgh
EH8 9AG Edinburgh
United Kingdom of Great Britain and Northern Ireland
Dr Abdulsalami Nasidi EchiTAb Study Group, Nigeria
No 18, Arochukwu Street
Garki 2, Abuja
Nigeria
Dr Elisabeth Neumeier GlaxoSmithKline Biologicals
01069 Dresden
Germany
15 July 2011
12
Dr Kathleen Neuzil PATH
2201 Westlake Ave.
Suite 200
98121 Seattle, WA
United States of America
Professor Angus Nicoll Senior Expert - Influenza Coordination
European Centre for Disease Prevention and Control (ECDC)
Tomtebodavagen 11A
17183, Stockholm
Sweden
Mrs Petronellar Nyagura Resource person
Counsellor
Health
Permanent Mission of the Republic of Zimbabwe to the
United Nations Office and International Organizations at Geneva
1292 Chambésy
Switzerland
Mr Frédéric Ors Vice-President
Business Development
Medicago inc.
G1V 3V9 Quebec
Canada
Dr Albert Osterhaus Head of the Department of Virology, Erasmus University
Rotterdam 3015 GE
The Netherlands
Dr Bram Palache Director, Global Government Affairs
Global Government Affairs
Abbott
1381 CP Weesp
The Netherlands
Ms Catherine Patterson Health Attaché
The Permanent Mission of Australia to the United Nations Office and
Other International Organizations at Geneva
1040 Brussels
Belgium
15 July 2011
13
Dr Michael Perdue Director, Division of Influenza & Emerging Diseases
Biomedical Advanced Research & Development Authority (BARDA)
US Department of Health and Human Services (HHS)
20201 Washington DC
United States of America
Dr Samuel Ponce de Leon General Director
Laboratorios de Biologicos y Reactivos de Mexico, S.A. de C.V
06000 DF Mexico
Mexico
Mr Kittisak Poopipatpol Influenza Plant Manager
Biological Products
Government Pharmaceutical Organization
10400 Bangkok
Thailand
Dr Firdausi Qadri Senior Scientist and Head
Immunology Laboratory
ICDDR,B
68, Shaheed Tajuddin Ahmed Sarani
Mohakhali, Dhaka-1212
Bangladesh
Dr Barbara Raymond Director
Pandemic Preparedness
Public Health Agency of Canada
K1A 0K9 Ottawa
Canada
Professor K. Srinath Reddy President
Public Health Foundation of India
110016 New Delhi
India
Dr Daniel Reynders Head of Service
International Relations
FPS Health, Food Chain Safety and Environment
1060 Brussels
Belgium
15 July 2011
14
Dr Byung Geon Rhee President
Green Cross Corporation
446-770 Yongin
Republic of Korea
Dr James S. Robertson Principal Scientist
Virology
National Institute for Biological Standards and Control (NIBSC)
EN6 3QG Potters bar
United Kingdom of Great Britain and Northern Ireland
Dr Robin A. Robinson ASPR Deputy Assistant Secretary and BARDA Director
Office of Biomedical Advanced Research & Development Authority (BARDA)
US Department of Health and Human Services (HHS)
20201 Washington DC
United States of America
Mr Nabil Safrany European Commission
2920 Luxemburg
Luxemburg
Dr Vilma Savy Head Respiratory Virus Laboratory
Virology
National Influenza Centre - Instituto C.G. Malbran Salud (ANLIS)
1281 Buenos Aires
Argentina
Dr Pathom Sawanpanyalert Deputy Director General
Department of Medical Sciences
Ministry of Public Health Thailand
11000 Muang, Nonthaburi
Thailand
Dr Kristine Sheedy Associate Director for Communication Science
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
30333 Atlanta
United States of America
15 July 2011
15
Ms Jane Shepard Baxter AG
A-1221 Vienna
Austria
Dr Rumondang Simanjuntak Head of Sub Directorate of Inspection and Certification of Therapeutic and Household Products
National Agency of Drug and Food Control
10560 Jakarta Selatan
Indonesia
Dr Surinder Singh Drug Controller General (India)
Central Drugs Standard Control Organization
Ministry of Health & Family Welfare
New Delhi
India
Dr Jaspal Sokhey Consultant in Vaccinology,
Ex Director CRI, Kasauli (HP),
New Delhi
Professor Raymond E. Spier Editor-in-Chief
Vaccine Series Elsevier
EX1 2AH Exeter, Devonshire
United Kingdom of Great Britain and Northern Ireland
Dr Philippe Saudan VP Research
Cytos Biotechnology AG
Wagistrasse 25
8952 Schlieren
Switzerland
Dr Klaus Stohr Vice President
Global Head - Influenza Franchises
Novartis Vaccines and Diagnostics
02113 Cambridge
United States of America
15 July 2011
16
Dr Mahendra Suhardono Production Director
Bio Farma
40161 Bandung
Indonesia
Dr Miodrag Stamenkovic Medicines and Medical Devices Agency of Serbia,
Ulofa Palmea 26
1000 Belgrade
Serbia
Dr Teiji Takei Director, International Cooperation Office
International Affairs Division
Ministry of Health, Labour and Welfare
100-8916 Tokyo
Japan
Dr Masato Tashiro Director
Influenza Virus Research Center
WHO Collaborating Center for Reference and Reserch on Influenza, National Institute of
Infectious Diseases, Tokyo
208-0011 Tokyo
Japan
Mrs Prapassorn Thanaphollert (Tim) Head of Biological Products Section
Bureau of Drug Control
Food and Drug Administration
11000 Nonthaburi
Thailand
Dr Sit Thirapakpoomanunt Director of the Viral Division
Biological Product
The Government Pharmaceutical Organization
10400 Bangkok
Thailand
Mr Patrick Tippoo R&D Manager
Biovac Institute
7430 Pinelands
South Africa
15 July 2011
17
Professor Oyewale Tomori Vice Chancellor
Department of Microbiology
Redeemer's University
3005 Redemption City
Nigeria
Mr Bill Turner Head
Office of Manufacturing and Quality
TGA
PO Box 100 Woden ACT 2006
Dr Chu Dang Trung Director, Legislation and International Integration Division
Drug Administration of Vietnam
Ministry of Health
Hanoi
Viet Nam
Dr Vadim Tsvetnitsky Vaccine Development Global Program
Program for Appropriate Technology in Health
20001 Washington DC
United States of America
Dr Dori Ugiyadi Senior Manager for Viral Vaccine Production
Bio Farma
40161 Bandung 40161
Indonesia
Mr Federico Vigano Global Commercial Director, Flu Portfolio
Glaxosmithkline Biologicals
Rixensart
Belgium
Dr Ildiko Visontai Deputy Director
National Center For Epidemiology
1097 Budapest
Hungary
15 July 2011
18
Ms Hui Wang Assistant General Manager
Beijing Tiantan Biological Products Co., Ltd.
100024 Beijing
The People's Republic of China
Mr Michael Wanner Vice-President
US Operations
Medicago inc.
G1V 3V9 Quebec
Canada
Dr Michael Watson IFPMA, B&V Chair
Vice President
Global Immunisation Policy
Sanofi Pasteur
69367 Lyon Cedex 7
France
Dr Bruce G. Weniger Associate Editor
Vaccine (Elsevier)
30345 Atlanta
United States of America
Dr Emelia Dwiyanti Wibowo Head Secretary of Production Directorate
Production Directorate
Bio Farma
40161 Bandung
Indonesia
Dr Suwit Wibulpolprasert Senior Advisor on Disease Control
Office of Permanent Secretary
Ministry of Public Health
11000 Nonthaburi
Thailand
Dr Ponthip Wirachwong Head of Medical Sciences Research Group
Research and Development Institute
Government Pharmaceutical Organization
10400 Bangkok
Thailand
15 July 2011
19
Mrs Sara Wongjaroen Department of Medical Sciences
MOPH
11000 Nonthaburi
Thailand
Mr Sathaporn Wongjaroen Director General
Department of Medical Sciences
MOPH
11000 Nonthaburi
Thailand
Dr Endang Woro Director
Directorate of Drug and Biological Product Evaluation
National Agency of Drug and Food Control
10570 Jakarta Pusat
Indonesia
Mrs Assmaa Yousry Head
Biologicals Product Registration Department
Central Administration for Pharmaceutical Affairs
Egyptian Drug Authority
+202 Cairo
Egypt
Dr Hongjie Yu Deputy Director
Office for Disease Control and Emergency Response
Chinese Center for Disease Control & Prevention
102206 Beijing
The People's Republic of China
Professor Maria Zambon Director, Reference Microbiology Services
Health Protection Agency
NW9 5EQ London
United Kingdom of Great Britain and Northern Ireland
Professor Hamdallah H. Zedan Chairman & CEO of EGYVAC
The Egyptian Organization for Biological Products and Vaccines (Vacsera)
Dokki Giza
Egypt
15 July 2011
20
Dr Christian Zidorn Scientific Officer, DG Research and Innovation
Health Research / Infectious diseases
European Commission
B-1050 Brussels
Belgium
WHO SECRETARIAT Dr Claudia Alfonso Scientist
Immunization, Vaccines and Biologicals/Quality, Safety and Standards (IVB/QSS)
Headquarters, Geneva, Switzerland
Ms Angela Baffoe Administration Assistant
Immunization, Vaccines and Biologicals /Initiative for Vaccine Research (IVB/IVR)
Headquarters, Geneva, Switzerland
Ms Florence Barthelemy Administration Assistant
Innovation, Information, Evidence and Research (IER)
Headquarters, Geneva, Switzerland
Ms Janna Breteler Intern
Immunization, Vaccines and Biologicals /Initiative for Vaccine Research (IVB/IVR)
Headquarters, Geneva, Switzerland
Dr Flavia Bustreo Assistant Director-General
Family, Women's and Children's Health (FWC)
Headquarters, Geneva, Switzerland
Ms Hannah Sarah Faich Project Officer
Innovation, Information, Evidence and Research (IER)
Headquarters, Geneva, Switzerland
Dr Martin Howell Friede Scientist
Innovation, Information, Evidence and Research (IER)
Headquarters, Geneva, Switzerland
Dr Keiji Fukuda Assistant Director-General
Health Security and Environment (HSE)
Headquarters, Geneva, Switzerland
15 July 2011
21
Dr Joachim Maria Hombach Scientist
Immunization, Vaccines and Biologicals /Initiative for Vaccine Research (IVB/IVR)
Headquarters, Geneva, Switzerland
Dr Shafiqul Hossain Technical Officer
Expanded Programme on Immunization
Regional Office for the Western Pacific (WPRO)
Manila, Philippines
Mrs Anne Marie Huvos Technical Officer
Health Security and Environment (HSE)
Headquarters, Geneva, Switzerland
Dr Marie-Paule Kieny Assistant Director-General
Innovation, Information, Evidence and Research (IER)
Headquarters, Geneva, Switzerland
Dr Jayantha Bandula L. Liyanage Medical Officer
SE/VPD Vaccine Preventable Diseases
Regional Office for South-East Asia (SEARO)
New Delhi, India
Dr Rebecca Mae Martin Medical Officer
EU/CDS Communicable Diseases
Regional Office for Europe (EURO)
Copenhagen, Denmark
Ms Stefanie Meredith Meeting Rapporteur
Global Health Consulting
Dr Anthony Wayne Mounts Medical Officer
Disease Monitoring, Assessment and Control/Health Security and Environment (HSE)
Headquarters, Geneva, Switzerland
Dr Richard Mihigo Medical Officer
Immunization Vaccines Development
Regional Office for Africa (AFRO)
Brazzaville, Congo
15 July 2011
22
Dr Faith McLellan Information Manager
Health Security and Environment (HSE)
Headquarters, Geneva, Switzerland
Dr Pem Namgyal Scientist
Immunization, Vaccines and Biologicals /Initiative for Vaccine Research (IVB/IVR)
Headquarters, Geneva, Switzerland
Dr Jean-Marie Okwo-Bele Director
Immunization, Vaccines and Biologicals (IVB)
Headquarters, Geneva, Switzerland
Dr Laszlo Palkonyay Medical Officer
Immunization, Vaccines and Biologicals/ Quality, Safety and Standards (IVB/QSS)
Headquarters, Geneva, Switzerland
Mr James Pfitzer III Technical Officer
Health Security and Environment (HSE)
Headquarters, Geneva, Switzerland
Dr Alba Maria Ropero Alvarez Medical Officer
Immunization Unit
Regional Office for the Americas (AMRO)
Washington DC, USA
Dr Cathy Ellen Roth Medical Officer
Biorisk Reduction for Dangerous Pathogens/Health Security and Environment (HSE)
Headquarters, Geneva, Switzerland
Mrs Dalia Samhouri Technical Officer
EM/DCD Division of Communicable Disease Control
Regional Office for the Eastern Mediterranean (EMRO)
Cairo, Egypt
Dr Natasha Shapovalova Technical Officer
Immunization, Vaccines and Biologicals /Initiative for Vaccine Research (IVB/IVR)
Headquarters, Geneva, Switzerland
15 July 2011
23
Ms Erin Grace Sparrow Project Officer
Innovation, Information, Evidence and Research (IER)
Headquarters, Geneva, Switzerland
Dr Siu Lun (John)Tam Technical Officer
Immunization, Vaccines and Biologicals /Initiative for Vaccine Research (IVB/IVR)
Headquarters, Geneva, Switzerland
Mr Guido Torelli Administrative Officer
Innovation, Information, Evidence and Research (IER)
Headquarters, Geneva, Switzerland
Dr Tony Waddell Meeting Rapporteur
9 Sidney Close, Stanley, Co Durham, DH9 6UH
United Kingdom of Great Britain and Northern Ireland
Dr David Wood Coordinator
Immunization, Vaccines and Biologicals/ Quality, Safety and Standards (IVB/QSS)
Headquarters, Geneva, Switzerland